-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS INC - FDA CLEARS IND FOR PHASE 1/2 STUDY OF ORAL ELRAGLUSIB IN ADVANCED CANCER PATIENTS

Reuters·05/11/2026 11:00:01

Please log in to view news